Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)

This study has been completed.
Sponsor:
Collaborator:
Federal Ministry of Education and Reserach (BMBF)
Information provided by:
University Hospital, Essen
ClinicalTrials.gov Identifier:
NCT01119729
First received: May 7, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted

May 7, 2010
May 7, 2010
Not Provided
Not Provided
Prevalence of cardiovascular diseases
Prevalence of cardiovascular diseases including coronary artery disease, congestive heart failure, peripheral arterial disease, cerebrovascular events, and valvular diseases.
Same as current
No Changes Posted
Prevalence of cardiovascular disorders
Prevalence of cardiovascular disorders determined by electrocardiography, exercise testing, echocardiography, blood samples.
Same as current
Not Provided
Not Provided
 
Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)
Not Provided

Human immunodeficiency virus (HIV) infection has been associated with a variety of cardiovascular diseases. Even most industrialised countries exhibit a growing and aging population of HIV-infected patients in the majority treated with antiretroviral drugs, the investigators still do not know much about the impact of cardiovascular diseases in this group of patients. The present study is an ongoing trial that was conducted as a prospective and multicentre survey, being schemed to analyse the frequency and clinical course of cardiac disorders in HIV-infected patients.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

The study population included outpatients who were at least 18 years of age, had a known HIV-infection and exhibited a stable disease status within 4 weeks before inclusion of the trial. Patients were recruited during a 20-month period in a consecutive manner from September 2004 to May 2006. Written informed consent was obtained from all participants

  • Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection.
  • Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors,
  • HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral Medication
Not Provided
HIV-infected Outpatients

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
803
Not Provided
Not Provided

Inclusion Criteria:

  • Age > 18 years
  • Known HIV-infection
  • Outpatients
  • Written informed consent

Exclusion Criteria:

● Acute cardiovascular disease or unstable hemodynamic status in the three weeks before inclusion

• Pregnancy

Both
18 Years and older
Not Provided
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT01119729
FKZ 01GI0205
Yes
PD Dr. med. Till Neumann, FESC, Competence Network of Heart Failure
University Hospital, Essen
Federal Ministry of Education and Reserach (BMBF)
Not Provided
University Hospital, Essen
May 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP